COHORT HOST MASTER SERVICES AGREEMENT ===================================== Effective Date: 2026-04-29 Cohort: {{cohort_id}} Host: {{host_name}} ({{host_jurisdiction}}) Platform: Peptide MD Research, Inc. 1. SCOPE The Host operates the Cohort identified above on the Peptide MD platform ("Platform") under the OEA-V1 commit-reveal protocol. The Host commits to pre-registering the primary endpoint and analysis plan before recruitment opens, and to publishing the reveal at the bound window. 2. PRE-REGISTRATION INTEGRITY The Host MUST NOT alter the analysis plan after the OEA-V1 commit hash is published. Permissible amendments are limited to (a) safety-driven changes that pause enrollment, and (b) typo corrections that do not affect the canonical-JSON dialect of the analysis plan. Any other change voids the commit and the cohort is marked withdrawn on /changelog. 3. MONITORING The Host MUST review wearable and PRO anomaly flags within 72 hours and record a continue/withdraw decision per participant. Anomaly logs are public on the cohort journey page. 4. REVEAL WINDOW At the bound reveal timestamp the Host publishes (a) the plain-text analysis plan, (b) the participant Merkle proofs, (c) the per-participant endpoint observations. Late reveals are flagged on the cohort detail page and downgrade the Host's reputation by one tier. 5. LIABILITY The Platform makes no representation about the cohort's outcomes. The Host indemnifies the Platform for claims arising from the Host's research operations, including ethics or regulatory failures. 6. TERM This MSA remains in effect for the duration of the Cohort plus 24 months of post-reveal data retention. 7. GOVERNING LAW {{governing_law}} (typical: Delaware, US; Netherlands, EU). Signatures: Host: Platform: ______________________ ______________________ {{host_name}} Peptide MD Research, Inc. Date: 2026-04-29 Date: 2026-04-29 - TEMPLATE ONLY · NOT LEGAL ADVICE · HAVE COUNSEL REVIEW BEFORE SIGNING -